Neelapu, Sattva (Faculty Profile)

View Profile

Faculty Profile

Last Modified Time: 12:49:15 PM Fri, 12 Feb 2021

Contact Information
Sattva Neelapu	Associated Profiles
Professor, Lymphoma/Myeloma, Cancer Medicine, UT MD Anderson Cancer Center


SNeelapu@mdanderson.org Web Link
Lymphoma, Follicular Lymphoma, B-Cell Lymphoma, Rituximab, Chimeric Antigen Receptors, Mantle-Cell Lymphoma, T-Lymphocytes, Large B-Cell Diffuse Lymphoma

Professional Preparation
Research and Expertise
Affiliations
Appointments

Professional Preparation

Degree	Major	Institution	Year
MBBS	Medicine	Jawaharlal Institute of Post-Graduate Medical Education and Research	1991

Research and Expertise

Research Interests

As a physician-scientist at MD Anderson, Dr. Sattva S Neelapu is focused on clinical and translational development of novel immunotherapies for B-cell malignancies. His laboratory characterized some of the major immunosuppressive mechanisms in the tumor microenvironment of B-cell malignancies, identified TCL1 as a novel shared tumor-associated antigen for B-cell lymphomas, and investigated novel targets for CAR T-cell therapy in lymphoma and myeloma. His work on the pivotal trial of axicabtagene ciloleucel CD19 CAR T-cell therapy in aggressive B-cell lymphomas led to its FDA approval as the first CAR T therapy for lymphoma. Dr. Neelapu has authored or co-authored over 150 publications.

Publications/Creative Works

Click here to search for this faculty member's publications on PubMed.

Affiliations

Research Consortia

Gulf Coast Consortia Immunology Cluster

Appointments

Title	Department / School	Institution
Professor	Lymphoma/Myeloma, Cancer Medicine	UT MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.